483
Hubei Yitai Pharmaceutical Co., LtdHubei Yitai Pharmaceutical Co., Ltd – FDA 483, Dec 13, 2024
Record Details
Hubei Viti Pharmaceutical Co., Ltd, an API manufacturer in Tianmen, Hubei Province, China, was cited for significant deficiencies in its quality control systems. The inspection revealed a repeat failure to implement an adequate stability testing program for its API drug products and issues with laboratory controls. Specifically, the firm lacked suitable and verified analytical test methods for both finished products and critical raw materials.
View Company Profile
ID · d468981e-d7a9-43e7-ac4d-ee85b077f129
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.